The global anticonvulsants market is experiencing significant growth, driven by the increasing prevalence of epilepsy and other neurological disorders. Factors such as advancements in drug formulations, rising awareness of epilepsy, and the demand for effective treatment options contribute to market expansion. Moreover, the growing geriatric population, prone to seizure disorders, further amplifies the market's potential. North America holds a substantial share, attributed to high healthcare spending and robust research activities. In contrast, the Asia-Pacific region is emerging as a key player due to improving healthcare infrastructure and increasing patient populations. The market is characterized by a competitive landscape featuring numerous pharmaceutical companies focusing on innovation and strategic partnerships to enhance their product offerings.
